Qyresearchreports include new market research report "Global Generic Drugs Market Research Report 2018" to its huge collection of research reports.
This report studies the global Generic Drugs market status and forecast, categorizes the global Generic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Get Report Sample and Customization: https://www.qyresearchreports.com/sample/sample.php?rep_id=1815608&type=S
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
The global Generic Drugs market is valued at 210800 million US$ in 2017 and will reach 451800 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.
The major manufacturers covered in this report
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Key Stakeholders
Generic Drugs Manufacturers
Generic Drugs Distributors/Traders/Wholesalers
Generic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Browse Table of Content @ https://www.qyresearchreports.com/report/global-generic-drugs-market-research-report-2018.htm/toc
Table of Contents
1 Generic Drugs Market Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Generic Drugs Segment by Type (Product Category)
1.3 Global Generic Drugs Segment by Application
1.4 Global Generic Drugs Market by Region (2013-2025)
1.5 Global Market Size (Value) of Generic Drugs (2013-2025)
1.5.1 Global Generic Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Generic Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Generic Drugs Market Competition by Manufacturers
2.1 Global Generic Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.2 Global Generic Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Generic Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Generic Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Generic Drugs Market Competitive Situation and Trends
List of Tables and Figures
Figure Picture of Generic Drugs
Figure Global Generic Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Generic Drugs Production Market Share by Types (Product Category) in 2017
Figure North America Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com
Blog – http://qyresearch-group.blogspot.com/
This report studies the global Generic Drugs market status and forecast, categorizes the global Generic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Get Report Sample and Customization: https://www.qyresearchreports.com/sample/sample.php?rep_id=1815608&type=S
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
The global Generic Drugs market is valued at 210800 million US$ in 2017 and will reach 451800 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.
The major manufacturers covered in this report
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Key Stakeholders
Generic Drugs Manufacturers
Generic Drugs Distributors/Traders/Wholesalers
Generic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Browse Table of Content @ https://www.qyresearchreports.com/report/global-generic-drugs-market-research-report-2018.htm/toc
Table of Contents
1 Generic Drugs Market Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Generic Drugs Segment by Type (Product Category)
1.3 Global Generic Drugs Segment by Application
1.4 Global Generic Drugs Market by Region (2013-2025)
1.5 Global Market Size (Value) of Generic Drugs (2013-2025)
1.5.1 Global Generic Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Generic Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Generic Drugs Market Competition by Manufacturers
2.1 Global Generic Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.2 Global Generic Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Generic Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Generic Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Generic Drugs Market Competitive Situation and Trends
List of Tables and Figures
Figure Picture of Generic Drugs
Figure Global Generic Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Generic Drugs Production Market Share by Types (Product Category) in 2017
Figure North America Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com
Blog – http://qyresearch-group.blogspot.com/
No comments:
Post a Comment